Home/Filings/4/0000950170-25-007852
4//SEC Filing

Shetzline Michael 4

Accession 0000950170-25-007852

CIK 0001446847other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 5:04 PM ET

Size

4.7 KB

Accession

0000950170-25-007852

Insider Transaction Report

Form 4
Period: 2025-01-17
Shetzline Michael
SVP, CMO, Head-Res&Drug
Transactions
  • Award

    Class A Common Stock

    2025-01-17+48,224461,943 total
Footnotes (1)
  • [F1]Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 2, 2022. The earned PSUs were certified and vested on January 17, 2025.

Documents

1 file

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001808509

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:04 PM ET
Size
4.7 KB